These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21568358)

  • 41. Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata.
    Lanas A; Carrera-Lasfuentes P; García-Rodríguez LA; García S; Arroyo-Villarino MT; Ponce J; Bujanda L; Calleja JL; Polo-Tomas M; Calvet X; Feu F; Perez-Aisa A
    Scand J Gastroenterol; 2014 Oct; 49(10):1181-90. PubMed ID: 25144754
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proton-pump inhibitors for acute peptic ulcer bleeding.
    Erstad BL
    Ann Pharmacother; 2001 Jun; 35(6):730-40. PubMed ID: 11408992
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost effectiveness of esomeprazole compared with omeprazole in the acute treatment of patients with reflux oesophagitis in the UK.
    Wahlqvist P; Junghard O; Higgins A; Green J
    Pharmacoeconomics; 2002; 20(4):279-87. PubMed ID: 11950384
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost implications of administering intravenous proton pump inhibitors to all patients presenting to the emergency department with peptic ulcer bleeding.
    Gagnon YM; Levy AR; Eloubeidi MA; Arguedas MR; Rioux KP; Enns RA
    Value Health; 2003; 6(4):457-65. PubMed ID: 12859587
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of famotidine on recurrent bleeding after successful endoscopic treatment of bleeding peptic ulcer.
    Kamada T; Hata J; Kusunoki H; Kido S; Hamada H; Aoki R; Nishida T; Komoto K; Todo H; Sumioka M; Tanimoto T; Sanuki E; Sumii K; Ogoshi H; Hidaka T; Dongmei Q; Chayama K; Haruma K
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():73-8. PubMed ID: 15943851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: a case-control study.
    Tseng GY; Fang CT; Lin HJ; Yang HB; Tseng GC; Wang PC; Liao PC; Cheng YT; Huang CH
    Aliment Pharmacol Ther; 2009 Aug; 30(4):406-13. PubMed ID: 19485981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer.
    Lanas A; Artal A; Blás JM; Arroyo MT; Lopez-Zaborras J; Sáinz R
    J Clin Gastroenterol; 1995 Sep; 21(2):103-6. PubMed ID: 8583073
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis.
    Liang CM; Lee JH; Kuo YH; Wu KL; Chiu YC; Chou YP; Hu ML; Tai WC; Chiu KW; Hu TH; Chuah SK
    BMC Gastroenterol; 2012 Mar; 12():28. PubMed ID: 22455511
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage.
    Lai KC; Hui WM; Wong BC; Hu WH; Lam SK
    Aliment Pharmacol Ther; 2000 Aug; 14(8):1071-6. PubMed ID: 10930902
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Intravenous omeprazole versus ranitidine in the treatment of hemorrhagic duodenal ulcer: a prospective randomized study].
    Cardi M; Muttillo IA; Amadori L; Barillari P; Sammartino P; Arnone F; Signorelli C; Bolognese A
    Ann Chir; 1997; 51(2):136-9. PubMed ID: 9297869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding.
    Liu N; Liu L; Zhang H; Gyawali PC; Zhang D; Yao L; Yang Y; Wu K; Ding J; Fan D
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1473-9. PubMed ID: 22646140
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of proton pump inhibitors on the outcomes of peptic ulcer bleeding: comparison of event rates in routine clinical practice and a clinical trial.
    Lanas A; Polo-Tomas M; García-Rodríguez LA; García S; Arroyo-Villarino MT; Ponce J; Bujanda L; Calleja JL; Calvet X; Feu F; Perez-Aisa A; Sung JJ
    Scand J Gastroenterol; 2013 Mar; 48(3):285-94. PubMed ID: 23298283
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial.
    Chan FK; Wong VW; Suen BY; Wu JC; Ching JY; Hung LC; Hui AJ; Leung VK; Lee VW; Lai LH; Wong GL; Chow DK; To KF; Leung WK; Chiu PW; Lee YT; Lau JY; Chan HL; Ng EK; Sung JJ
    Lancet; 2007 May; 369(9573):1621-6. PubMed ID: 17499604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A head to head comparison of oral vs intravenous omeprazole for patients with bleeding peptic ulcers with a clean base, flat spots and adherent clots.
    Yilmaz S; Bayan K; Tüzün Y; Dursun M; Canoruç F
    World J Gastroenterol; 2006 Dec; 12(48):7837-43. PubMed ID: 17203530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Esomeprazole for the treatment of peptic ulcer bleeding.
    den Hoed CM; Kuipers EJ
    Expert Rev Gastroenterol Hepatol; 2010 Dec; 4(6):679-95. PubMed ID: 21108587
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous omeprazole prevents rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized controlled study.
    Chua RT; Lin HJ; Wang K; Perng CL; Lo WC; Lee CH; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Feb; 57(2):139-45. PubMed ID: 8634929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study.
    Hasselgren G; Lind T; Lundell L; Aadland E; Efskind P; Falk A; Hyltander A; Söderlund C; Eriksson S; Fernström P
    Scand J Gastroenterol; 1997 Apr; 32(4):328-33. PubMed ID: 9140154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
    Santander C; Grávalos RG; Gómez-Cedenilla A; Cantero J; Pajares JM
    Am J Gastroenterol; 1996 Aug; 91(8):1549-52. PubMed ID: 8759659
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ulcers and nonvariceal bleeding.
    Church NI; Palmer KR
    Endoscopy; 2003 Jan; 35(1):22-6. PubMed ID: 12510222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intermittent versus continuous pantoprazole infusion in peptic ulcer bleeding: a prospective randomized study.
    Yüksel I; Ataseven H; Köklü S; Ertuğrul I; Başar O; Odemiş B; Ibiş M; Saşmaz N; Sahin B
    Digestion; 2008; 78(1):39-43. PubMed ID: 18824852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.